API Consumer Brands
API Consumer Brands has decided to close its Auckland manufacturing plant and withdraw from the New Zealand pharmaceutical market.
API in New Zealand
API have notified the Australian Stock Exchange of their decision to focus on their retail and distribution businesses.
We can assure people that there is no issue with the current supply of API’s publicly funded products.
Products currently supplied by API
|Citalopram hydrobromide||Tab 20 mg||PSM Citalopram||2479621|
|Codeine phosphate||Tab 15 mg||PSM||206717|
|Codeine phosphate||Tab 30 mg||PSM||206733|
|Codeine phosphate||Tab 60 mg||PSM||206776|
|Dexamfetamine sulfate||Tab 5 mg||PSM||2461374|
|Domperidone||Tab 10 mg||Pharmacy Health||2549093|
|Glycerol||Suppos 3.6 g||PSM||778338|
|Hydrocortisone||Crm 1%||Hydrocortisone (PSM)||277002|
|Hydrocortisone||Crm 1%||Hydrocortisone (PSM)||2580462|
|Isoniazid||Tab 100 mg||PSM||267473|
|Methadone hydrochloride||Tab 5 mg||Methatabs||2565277|
|Oxytocin with ergometrine maleate||Inj 5 iu with ergometrine maleate 500 mcg per ml, 1 ml||Syntometrine||256269|
|Paracetamol||Oral liq 120 mg per 5 ml||Paracare||304905|
|Paracetamol||Oral liq 250 mg per 5 ml||Paracare Double Strength||306088|
|Pethidine hydrochloride||Tab 50 mg||PSM||259942|
|Phenobarbitone||Tab 15 mg||PSM||765481|
|Phenobarbitone||Tab 30 mg||PSM||439886|
|Prochlorperazine||Tab 3 mg buccal||Buccastem||340537|
|Sodium fluoride||Tab 1.1 mg (0.5 mg elemental)||PSM||358827|
We will be working closely with API to manage their exit from the New Zealand pharmaceutical market. We will need to do this on a case-by-case basis. This ensures our approach is the right one for each medicine.
We have issued a Future Procurement Opportunity (FPO) on the Government Electronic Tenders Service (GETS). One of the many options we're considering is issuing a competitive procurement process to secure alternative products. Suppliers interested in supplying these markets should register with GETS and subscribe to the FPO for more information. We welcome early feedback from suppliers to help plan our approach.
Who to contact
If you have questions about this issue, email firstname.lastname@example.org